Close Menu

This article from the Wall Street Journal reports on Celgene's acquisition of Pharmion, which makes treatments for patients with blood cancer. Celgene, a biotech company, will make the purchase for $2.9 billion in cash and stock in an effort "to become a major global player in developing and marketing blood-cancer drugs," according to the article.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.

The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.

Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.

In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.